• No results found

The Patients Summit 2014

N/A
N/A
Protected

Academic year: 2021

Share "The Patients Summit 2014"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

(1)

17-18 June 2014, London

Two day conference with tangible solutions to make your business truly patient centric

The Patients Summit 2014

Build trust:

redesign your business

around a better patient experience

Expert Speakers:

> Your business’ strategy for genuine

patient centricity: understand what this really

means and get the tools to structure your company

around a workable patient centricity strategy

> Understand what is important to your

patients: improve your offering with a sophisticated

understanding of patient need and work with all

relevant stakeholders to provide this

> Do more for your patients: go beyond the pill

to engage your patients through support programmes

for patients and their families

> A valuable partner: get the tools to fully engage

patients with their treatment and develop a reciprocal

relationship

> Revealing case studies and the chance to

meet your patients: the only conference with

practical, tangible solutions for pharma and medtech

companies shaped by the patients and HCPs

themselves

Soren Skovlund

Global Director, Patient Research and Engagement, Novo Nordisk

Ian Talmage

SVP Global Marketing, General Medicine, Bayer

Keith Allan

Head of Medical Advocacy,

Novartis

Matthias Borst

Vice-President/General Manager Diabetes Care Europe & EMA,

Beckton Dickinson

Hannah Gagen

Patient Engagement and External Affairs Manager,

Boehringer Ingelheim

Werner Bleilevens

Head of Patient Centricity,

Grünenthal

Paul Humphrey

Head of Patient Advocacy,

Genzyme

Esther Broer

Global Medical Affairs Manager,

Nutricia

Jacqueline Allan

Director,

Diabetes with Eating Disorders

Diana Vegh NHS Partnership Manager, ABPI John Church CEO, Arthritis Ireland

Lidia Rota Vender

President,

Italian Thrombosis and Cardiovascular Association Media Partners: Sponsor:

SAVE

600

Register before 28th March 2014
(2)

Dear Colleagues,

At eyeforpharma, we have been running The Patient Summit for 10 years, however, now more than ever, it's gratifying to see the patient experience reach the top of company agendas.

During my research, one need became clear - the ability to bring your patients to the forefront of everything. Pharma knows that patients are important, but is looking for practical structural solutions and effective and compliant ways to communicate and engage its patients to ensure compliant, proactive patients. In essence, patient centricity just means a consistent focus on the patient. If pharma can succeed in this, better relations with stakeholders, increased adherence and above all, trust in the industry, will be the natural result.

But, it’s clear, a lot of work still needs to be done before we can say that we are truly succeeding achieving real patient

centricity. There is still more pharma can do to cater for its patients and ensure its good reputation.

That’s why The Patient Summit EU 2014 focuses on just that. The agenda will cover a focus on real health solutions, not just medicine, as well as practical ways you can communicate with your patients and understand what real value means. With case studies from Novo Nordisk, Bayer, Grünenthal, Boehringer Ingelheim, Genzyme, Beckton Dickinson, GSK, Novartis and MSD and representatives from UCB, Nutricia, The Belgian Heart League, Diabetes with Eating Disorders, The Italian Thrombosis and Cardiovascular Association, The Romanian Heart Foundation as well as patients, payers and HCPs, you’ll see how everyone involved in the patient journey can integrate to maximise the interactions you have with your patients and truly achieve your aims of adding value and

building trust in healthcare.

You’ll also get an an in-depth look the changing roles and relationships within your organisation and you’ll come away with a clear idea of the requirements needed to adapt.

This event will be the only meeting place to discuss the future of your patients and I’m delighted that the speakers – both from pharma and elsewhere in healthcare – are eager to be forming your strategy for the future.

I look forward to seeing you in London! Kind regards,

Sophie Akister

VP Patient Engagement Global Event Director eyeforpharma +44(0)207 422 4322

[email protected]

Our Expert Speakers Include:

Pharma Speakers

Out of Industry Speakers

Soren Skovlund

Global Director, Patient Research and Engagement

Novo Nordisk Ian Talmage SVP Global Marketing, General Medicine Bayer Keith Allan Head of Medical Advocacy Novartis Hannah Gagen

Patient Engagement and External Affairs Manager

Boehringer Ingelheim

Werner Bleilevens

Head of Patient Centricity

Grünenthal

Paul Humphrey

Head of Patient Advocacy

Genzyme Esther Broer Global Medical Affairs Manager Nutricia Sameer Mistry

Regional Medical Director

Johnson & Johnson

Keir Woods

Director, Oncology

GlaxoSmithKline

Matthias Borst,

Vice-President/General Manager Diabetes Care Europe & EMA,

Beckton Dickinson

Katia Baeke

Patient Champion

UCB

Maciej Gajewski

Director European Government Relations & Public Policy

Shire

Jack Whelan

Cancer Survivor, ePatient, Patient Research Advocate

Debi Bhattacharya

Senior Lecturer in Pharmacy Practice

University of East Anglia

Freddy Van de Casseye

President-General Manager,

Belgium Heart League

Jacqueline Allan

Director, Diabetes with Eating Disorders

Lidia Rota Vender

President, Italian Thrombosis and

Cardiovascular Association

Professor Dan Gaita

FESC President

Romanian Heart Foundation

Detlev Parow, Head of Department of Care Management Development,

DAK Gesundheit

Diana Vegh

NHS Partnership Manager,ABPI

John Church

CEO, Arthritis Ireland

Rob Hicks

GP, NHS

Stephen Head

(3)

Your conference at a glance

DAY 1

17 June 2014

THE TRUE VALUE IN BECOMING PATIENT

CENTRIC

• Understand what patient centricity means for you and

your business

• Realistically assess where the industry is, how has it

moved forward and how can it do more

• Implement the right organisational changes in your

company to ensure an integrated approach across your

business

• With case studies from Novo Nordisk, Bayer, Johnson &

Johnson and Grünenthal, learn how to transform your

organisation into something truly patient centric

UNDERSTAND YOUR PATIENTS AND WHAT

THEY CARE ABOUT

• Get the tools to assess what is important to your patients

and how your company can reflect this

• Offer patients the information they need to stay up to

date with their treatment plan

• Differentiate your company in the eyes of your payers

and physicians by offering them solutions which reflect

the needs of patients

Networking Drinks

DAY 2

18 June 2014

HOLISTIC HEALTHCARE FOR YOUR

PATIENTS, GOING BEYOND THE PILL

• How your company can do more, support programmes

for patients and their families to ensure a better patient

experience

• Personalise your patients’ treatment through involvement

in clinical trials

• Benchmark your support programmes against others in

the industry and get feedback from patients and patient

associations, physicians and payers

AN EFFECTIVE AND COMPLIANT

COMMUNICATION STRATEGY

• Guarantee you’re making the most of your communication

opportunities and working in-line with the regulations

• Understand where the patients are talking and capitalise

on new forms of data

• Engage the patients with their treatment and improve

your relationship and ensure a fruitful partnership and

patient adherence

Need more?

UPGRADE TO A

DIAMOND PASS AND

RECEIVE YOUR VALUE

ADDED SERVICES

REPORT, WHICH

INCLUDES:

• Understand the roadmap that

it is necessary to follow in

order for companies to truly

redefine the way they operate

so services can be fully

integrated.

• Understand how to build trust

between pharma and other

stakeholders, and achieve

senior management buy in

from those who have helped

shaped the progression of

services within their company.

• Detailed interviews with all

stakeholders, pharma, payers,

physicians, regulators and

patient advocacy groups.

(4)

Build trust in your business through continued patient centricity after the drug is on the market

>Learn why patient centricity can make dramatic improvements to pharmacovigiliance

>Improve your offering through consistently putting the patient at the forefront of the decision making process through capitalising on new forms of data

>Continue to work with HCPs to ensure trust in your company and your product

Sameer Mistry, Regional Medical Director,

Johnson & Johnson

HOW TO BE VALUED BY

YOUR PATIENTS

Understand the outcomes which are important to patients

>Get the tools to effectively collect and use evidence as to what patients need and find important

>Shift your value proposition from the physician to the patient

>Effectively measure the outcomes and effectiveness of various forms of treatment through sustained partnership with patients

Paul Humphrey, Head of Patient Advocacy,

Genzyme

Implement a ‘Patient Centric Selling Approach’

>Learn effective methods to gauge what patients want and need from products and services and recognise where there is unmet need

>Case study on Beckton Dickinson’s ‘Patient Centric Selling Approach’: learn how to implement knowledge of what patients want to build solutions which are meaningful and relevant to patients

>Support and educate HCPs in delivering this service

Matthias Borst, Vice-President/General Manager Diabetes Care Europe & EMA,

Beckton Dickinson

Understand the patient journey throughout and post-treatment to ensure you’re providing a positive patient experience

>Get the tools to get real insight into the patient pathway and their families and those that care for them

>Remove the ‘delay in the system’ for patients; keep the patients in the loop to avoid the feeling of being left in limbo

>Continue to monitor the patient journey post prescription to tell if you’re delivering on your brand promise

Keir Woods, Director of Oncology, GSK

PANEL: Learn how understanding patient and behaviour customer insight can help your business

> Understand what customer insight means and the tools to get it

> Ensure your patients are willing to listen to you by offering the sort of information they really need

> Know what patients are saying about their treatments through study of their behaviour on and engagement with social media sites and online forums

Katia Baeke, UCB

Keir Woods, Director of Oncology, GSK

Freddy Van de Casseye, President, Belgian Health League

PANEL: How to use your knowledge of patient need to attract the attention of physicians and payers

> Understand what will be persuasive to the physician and how to effectively collect this information

> Ensure reimbursement by providing treatment packages which have been developed in accordance with patient need

> Learn what payers think the role of pharma is with regard to patient centricity in the healthcare industry

Detlev Parow, Head of Care Management, DAK

Maciej Gajewski, Director European Public Policy,

Shire

Sameer Mistry, Regional Head Medical Affairs,

Johnson & Johnson

FOCUS ON HEALTH NOT

MEDICINE

A superior service: do more for your patients with continued support beyond the pill

> Recognise how each patient has unique physical and emotional needs beyond mere medicine

> Develop treatment plans and services for patients and their families to cater for their needs and problems post treatment

> Case study: Diabetes with Eating Disorders, learn how to reach out to those patients who are disillusioned with their treatment and not complying with their medication

Jacqueline Allan, Managing Director,

Diabetes with Eating Disorders A better relationship with patients:

recognise where patients see the gaps your company could fill

> Learn about the type of role the patients expect and want your company to play in their lives

> Bridge the gap between pharma and the patients: understand how you can effectively use and build upon customer feedback

> Ensure future feedback and advice by building long term partnerships with patients

Dr Lidia Rota Vender, Physician and Chairman,

Italian Thrombosis and Cardiovascular Association

THE REAL PATIENT CENTRIC

COMPANY

Differentiate your business with a strategy built around the patient experience

> Implement a consistent approach across all departments focussed on putting the patient at the centre of your company

> Understand the business case for putting the patient at the centre: what are you hoping to achieve and what practical changes are needed

> Learn how, through working with patient associations, you can involve the patient in all of your company’s global projects

Soren Skovlund, Global Director, Patient Research and Engagement, Novo Nordisk ‘Patient centricity’: learn how to move beyond the buzzword with a realistic assessment of the industry and your company

> Establish what has been achieved as a result of pharma moving away from the physician and towards patients: and what this evolution means for your own future plans

> Understand what is practically achievable within the political and bureaucratic environment for your company, are there ways to overcome certain obstacles?

> Is it solely the industry’s responsibility? Build an accurate picture of the other stakeholders – and create a system which enables payers, HCPs and others to help your company

Ian Talmage, SVP Global Marketing, General Medicine, Bayer

Put the patient at the centre through collaboration: the pharma company as a partner of the patient associations

> Learn how you can establish a mutually beneficial partnership with patient associations

> Learn how your company can be a real player in promoting health not just medicine promotion

> Case study: see how Arthritis Ireland and Pfizer harnessed relationships to effectively succeed in early intervention

John Church, CEO, Arthritis Ireland Ensure organisational cohesion and smooth relations between departments when shifting away from the physician and towards the patient

> Learn to balance the objective of each department against the overall important aim of becoming more patient centric

> Play your part: understand and implement what each function within the organisation must actually do to create the cohesive patient centric whole

> Determine whether to create/ improve a patient centricity business unit or whether patient representatives are needed in each department

Werner Bleilevens, Head of Patient Centricity,

(5)

ROUNDTABLE COMPETITION: Design your own patient support programme

> Learn how your company can deliver a superior service through understanding what patients look for from a support programme

> Examine your own techniques: benchmark your ideas against your peers and learn how to persuade those in your company and stakeholders of the merits of your programme

> Get feedback from HCPs, patients and patient associations as to the sort of services which will be valuable in providing extra support

Involve patients in clinical trials and ensure superior, personalised care and a closer relationship

> Learn how pharma can do more to inform patients about the opportunities: how targeted agents can be safer and more effective than traditional therapies

> Learn how and why the patient can be your most valuable partner and how both pharma and patients can profit from the relationship

> Ensure patient adherence and engagement through a personalised service

Jack Whelan, Cancer Survivor, ePatient, Patient Research Advocate

Ensure all those involved in the patient journey are completely integrated and working together to implement a patient centric strategy and provide a fuller service

> Emphasise the importance of patient centricity to your stakeholders so everyone has the same goals

> Establish internal advocates within your company who are working to actively serve the needs of your patients

> Achieve a better standard of care and facilitate business relationships through better connections with all customers - including payers and hospital account managers

Detlev Parow, Head of Care Management, DAK

PANEL: Work through HCPs: ensure your physicians and nurses are properly informed and adequately translating the benefits of your product to the patients

> Establish ways in which medical affairs teams can actively serve the needs of HCPs and establish an effective reciprocal partnership

> Make the most of your products: ensure HCPs are educated about the drugs and treatment patterns to effectively apply them to patients

> Your representative to the patients: receive continued and useful feedback from HCPs on the effectiveness of the drug

Esther Broer, Global Medical Affairs, Nutricia

Dr Lidia Rota Vender, Physician and Chairman,

Italian Thrombosis and Cardiovascular Association

Diana Vegh NHS Partnership Manager, ABPI

Stephen Head, GP, Nottinghamshire NHS Trust

Rob Hicks, Practising GP

Support patients’ choice and

independence through home treatments

> Involve patients with their treatment and ensure a shared care plan

> Provide patients with effective near home care and minimise dependence on HCPs by using IT and telehealth to improve decision making and care monitoring

> Hear about examples End of Life treatments which successfully managed to improve quality of life, provide tailored solutions and cater for unmet need

Stephen Head, Clinical Director, County Health Partnerships, Notts Healthcare Trust

GO FROM COMMUNICATION

AND ENGAGEMENT TO TRUST

Equip yourself to do more for patients: understand them, their families and those that care for them

> Understand how you can interact with patients: realise the difference between marketing to them and opening up a dialogue to better understand their needs

> Use effective and compliant communication techniques to truly meet patient needs and find better solutions

> Improve your relationship with those around the patient: how you can support their families and those who deliver their care

Hannah Gagen, Patient Engagement and External Affairs Manager, Boehringer Ingelheim

The Patient Voice: understand and work with the growth of the multi stakeholder coalition to represent patient views

> Principles and case studies from Novartis, understand how and why coalitions of patients themselves, are forming

> Learn what these coalitions want to achieve and how you can help them to build trust and a reciprocal partnership

> Capitalise on the benefits of working with disease area coalitions to influence how the physicians view your products

Keith Allan, Head of Medical Advocacy,

Novartis

How to empower an active patient community through a multichannel approach

> Understand the spectrum of online media able to engage patient communities and learn how your company can use them

> Ways to establish an informed dialogue between the patients and the HCPs

> Capitalise on the existence of online forums and other channels to understand patients’ needs and how you can provide support and therapy beyond the pill

Speaker to be revealed

Develop an effective working relationship with patient groups

> Understand the benefits of working effectively with patient groups

> Practical tips on how to develop a reciprocal relationship

> Offer practical solutions and support for groups helping patients manage lifelong conditions

Speaker to be revealed

Engender a generation of healthy patients through the promotion of active engagement in healthcare

> Understand how socio-economic factors can affect patient behaviour and how background can determine whether or not the patient is compliant with treatment

> Work with all stakeholders and political and economic players to ensure the optimum conditions for engaged patients

> The natural result: learn how engaged patients will also be compliant patients and give patients the tools to directly engage with their health

Dan Gaita, President, Romanian Heart Foundation

PANEL: Ensure patient adherence through engagement

> Get the tools to establish the patient as an effective player in their treatment to ensure better health outcomes and a supportive, compliant partner

> Use technological advances to deliver personalised care and build value and trust

> Come to effective solutions to ensure patients are more likely to persevere with their treatment based on understanding behaviour and providing fuller care services

> Create models which enable HCPs to flag when there are patterns of non-compliance with drug treatment

Debi Bhattacharya, Adherence Lecturer and Researcher, University of East Anglia

Jacqueline Allan, Managing Director,

Diabetes with Eating Disorders

Freddy Van de Casseye, President, Belgian Health League

Dan Gaita, President, Romanian Heart Foundation

(6)

Select a Diamond Pass today to ensure you benefit from this exclusive eyeforpharma report and save on your registration!

> We are dedicated to providing a forum where our attendees can learn about the most advanced and tailored solutions available on the market. > There are a limited number of spaces available for

companies with an innovative solution in the areas of emerging markets, global brand and pricing strategies and economic analysis.

This event offers you a unique opportunity to build new prospects and strengthen current business relationships.

Business Opportunities for Solution Providers

Opportunities available include:

> 1 to 1 meetings with key decision makers

> Take a speaking slot and address 200+ executives

> Show off your latest products and services in our exhibition hall > Build your brand with exclusive promotional opportunities > Host interactive workshops with core clients and prospects… > and much more!

If you want to meet with senior decision makers from

pharmaceutical and biotech companies across Europe then contact Richard Ellis on +44 (0) 207 375 7170

[email protected]

YOUR DIAMOND PASS

INCLUDES:

EX

CL

USIVE

Industry buzz around

last year’s event

Great event with great speakers

and networking opportunities. Great

to have a combination of industry,

physicians and patient groups speaking

at same meeting.

Manager Patient Group Relations –

Genzyme

Valuable, inspiring event with

shared practices.

Capabilities and Communications Lead

–GSK

Good to see the patient voice

gaining some momentum!

Senior Consultant - Complete Clarity

The exclusive eyeforpharma

Value Added Services report

Prepare your organisation for the

future with 'Beyond the Pill' services.

> REDEFINE YOUR BUSINESS MODEL:

A step-by-step guide in order for your company to truly redefine the way you operate so services can be fully integrated. > CASE STUDIES FROM THE LEADERS:

We look at real examples from Janssen Connect, AstraZeneca, GSK and Fresenius Medical Care.

> 360 DEGREE VIEW OF VALUE ADDED SERVICES: Detailed interviews with all stakeholders, pharma, payors, physicians, regulators and patient advocacy groups

(7)

Register NOW in 3 easy steps

I enclose a cheque for:

(Payable to FC Business Intelligence Ltd.)

Please invoice my company: Purchase Order Number:

Please charge my credit card: Amex Visa Mastercard

Credit card number:

Expiry date: Security number:

Name on card: Signature:

Mr/Mrs/Ms/Dr: First name: Last name:

Company: Position/Title:

Telephone: Fax: Email:

Address: Postcode: Country:

TERMS & CONDITIONS Places are transferable without any charge. Cancellations before 17 May 2014 incur an administrative charge of 25%. if you cancel your registration after 17 May 2014 we will be obliged to charge the full fee. Please note – you must notify eyeforpharma in writing of a cancellation, or we will be obliged to charge the full fee. The organizers reserve the right to make changes to the programme without notice. All prices displayed are exclusive of VAT unless otherwise stated but, VAT will be charged, where applicable, at the prevailing rate on the invoice date and the relevant details will appear on the invoice.

NB: FULL PAYMENT MUST BE RECEIVED BEFORE THE EVENT.

DESIGNED BY THE CREATIVE TREE LTD WWW.THECREATIVETREE.CO.UK

FAX THIS FORM TO

+44 207 375 7172

team discounts.

Contact the eyeforpharma team on

+44 207 375 7222 or

[email protected]

ONLINE:

Go to https://secure.eyeforpharma.com/patient/register.php

and submit your details for instant confirmation of your

place.

E-MAIL:

The eyeforpharma Registration Team at

[email protected]

FAX:

Send this form by fax to +44 207 375 7172

CALL:

eyeforpharma on +44 207 375 7222

4 EASY WAYS TO REGISTER TODAY!

1. SELECT YOUR REGISTRATION PACKAGE:

2. DELEGATE DETAILS:

3.

PAYMENT

:

Pass Features

DIAMOND PASSFull Access GOLD PASSMost Popular SILVER PASSStandard

> Access to the conference

> Access to speaker slide deck after the event

> Access to the full audio recording of the event

> EXCLUSIVE eyeforpharma Value Added Services Report (normally worth €2495)

For Pharma Companies

Pre Launch Special Price - Expires 27th January, 2014 2895 €1695 €1395

Super Early Bird Price - Expires 28th March, 2014 2995 €1795 €1495

Early Bird Price - Expires 26th April, 2014 3295 2095 1795

Last Chance Price - Expires 23rd May, 2014 3495 €2295 €1995

Full Price 3595 €2395 €2095

For Solution Providers

Pre Launch Special Price - Expires 27th January, 2014 3195 €1995 €1695

Super Early Bird Price - Expires 28th March, 2014 3295 2095 1795

Early Bird Price - Expires 26th April, 2014 3595 €2395 €2095

Last Chance Price - Expires 23rd May, 2014 3795 2595 2295

(8)

17-18 June 2014, London

Two day conference with tangible solutions to make your business truly patient centric

The Patients Summit 2014

Build trust:

redesign your business

around a better patient experience

Expert Speakers:

Soren Skovlund

Global Director, Patient Research and Engagement, Novo Nordisk

Ian Talmage

SVP Global Marketing, General Medicine, Bayer

Keith Allan

Head of Medical Advocacy,

Novartis

Matthias Borst

Vice-President/General Manager Diabetes Care Europe & EMA,

Beckton Dickinson

Hannah Gagen

Patient Engagement and External Affairs Manager,

Boehringer Ingelheim

Werner Bleilevens

Head of Patient Centricity,

Grünenthal

Paul Humphrey

Head of Patient Advocacy,

Genzyme

Esther Broer

Global Medical Affairs Manager,

Nutricia

Jacqueline Allan

Director,

Diabetes with Eating Disorders

Diana Vegh NHS Partnership Manager, ABPI John Church CEO, Arthritis Ireland

Lidia Rota Vender

President,

Italian Thrombosis and Cardiovascular Association Media Partners: Sponsor:

SAVE

600

Register before 28th March 2014

> Your business’ strategy for genuine

patient centricity: understand what this really

means and get the tools to structure your company

around a workable patient centricity strategy

> Understand what is important to your

patients: improve your offering with a sophisticated

understanding of patient need and work with all

relevant stakeholders to provide this

> Do more for your patients: go beyond the pill

to engage your patients through support programmes

for patients and their families

> A valuable partner: get the tools to fully engage

patients with their treatment and develop a reciprocal

relationship

> Revealing case studies and the chance to

meet your patients: the only conference with

practical, tangible solutions for pharma and medtech

companies shaped by the patients and HCPs

References

Related documents

The diagram is divided into four parts: (a) data collection from field and laboratory measurements were conducted; (b) atmospheric correction of hyperspectral images was performed

Even if most of the veterans who took advantage of Title II benefits would have attended college regard- less, the massive influx of seemingly regular Americans into the ivory

NBS identified two connected components of brain functional interactions at rest that significantly related to the participants’ scores on distinct patterns of thought,

Based on this data, Hobart home values have recorded the third highest annual rate of value growth albeit the growth remains well below that of Sydney and Melbourne.. Over the

Next step was mapping all processes of ITSCMM and CMMI-SVC with ITIL processes and design a Staged model, then collect all the goals and practices of each process of ITIL (and

The conflict between the spoken tradition of Arabic origin and the written tradition of Latin origin is fundamental in understanding the socio-cultural experience of the Maltese,

Based on the analysis of the collected data, it is pos- sible to perceive that the environmental dimension of sustainability is a determining factor for the arrangement of

Equipment and the Luxembourg Protocol thereto on Matters specific to Railway Rolling Stock (Second Edition) (2014) and the Official Commentary on the Convention on